“AI-Driven Visualization and Real-Time Decision Support”
- A prominent and evolving trend in the global video laryngoscope market is the integration of artificial intelligence (AI) and advanced imaging technologies to enhance visualization, accuracy, and clinical decision-making during intubation procedures. These innovations are transforming video laryngoscopes into intelligent diagnostic and procedural tools beyond traditional airway visualization
- For instance, companies such as Ambu A/S and Verathon are advancing their product lines with AI-powered video processing that provides automated landmark identification and guidance, improving first-pass success rates in difficult airway scenarios. Similarly, the GlideScope Go by Verathon offers a compact, portable solution with real-time video assistance, ideal for use in both hospital and pre-hospital environments
- AI algorithms are increasingly being used to detect anomalies, recommend optimal tube placement angles, and provide decision support during high-risk or emergency intubations. This trend enhances procedural safety and supports less experienced healthcare providers through guided visual cues, making advanced airway management more accessible and standardized
- The integration of video laryngoscopes into broader hospital IT systems and training platforms is also gaining traction, enabling real-time data capture, performance analytics, and integration into simulation-based medical education
- As AI capabilities evolve and demand for evidence-based clinical practices grows, the development of AI-assisted, network-connected video laryngoscopes is setting new standards in airway management. This shift is driving medical device manufacturers to innovate with compact, wireless, and cloud-integrated models designed to meet the diverse needs of hospitals, emergency services, and military settings
- The rising demand for precision, safety, and enhanced training tools is fueling the global shift toward intelligent, AI-enhanced video laryngoscope systems across both developed and emerging healthcare markets
